Effective Date: January 1, 2026
Information we collect
We may collect information you choose to provide, including your name, email address, phone number, general research interest, message content, and communication preferences. We may also receive basic technical information such as browser type, device information, pages visited, and approximate interaction data used to maintain website performance.
How information may be used
Information may be used to respond to your inquiry, provide general clinical trial inquiry support, manage communication preferences, maintain records, improve website usability, and comply with applicable obligations. We do not use this website to provide medical advice, diagnosis, or emergency support.
SMS privacy
If you opt in to text messages, your SMS consent status and mobile number are used to manage Nova Clinical Trial Group text communications. SMS opt-in data and consent records are not sold. Reply STOP to cancel text messages or HELP for help. Message and data rates may apply, and message frequency varies.
How we protect information
We use reasonable administrative, technical, and organizational safeguards intended to protect information from unauthorized access, misuse, or loss. No website or electronic transmission can be guaranteed completely secure.
Your choices
You may contact us to request an update to your submitted information or communication preferences. You may unsubscribe from SMS messages by replying STOP to a text message.
Contact
Nova Clinical Trial Group
130 Norfolk St, Newark, NJ 07103
Phone: 973-891-4190
Email: info@novactn.com